Quantitation of hepatitis C virus RNA in liver transplant recipients.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 8144005)

Published in Gastroenterology on April 01, 1994

Authors

O Chazouilleres1, M Kim, C Combs, L Ferrell, P Bacchetti, J Roberts, N L Ascher, P Neuwald, J Wilber, M Urdea

Author Affiliations

1: Department of Medicine, Veterans Administration Medical Center, San Francisco, California.

Articles citing this

Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens. Gut (1999) 1.44

Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol (1996) 1.31

Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol (1999) 1.26

Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat. Ann Fam Med (2004) 1.24

Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol (1998) 1.17

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol (2001) 1.17

Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol (1996) 1.09

Hepatitis C and liver transplantation. Gut (1999) 1.03

Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg (1999) 1.01

Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV. Gut Liver (2011) 0.89

Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut (2002) 0.89

Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg (1998) 0.86

Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients. Virus Res (2007) 0.85

The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation (1995) 0.84

Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem. World J Gastroenterol (2014) 0.83

Human liver transplantation as a model to study hepatitis C virus pathogenesis. Liver Transpl (2009) 0.79

Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad Med J (2002) 0.78

Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol (2014) 0.77

Hepatitis C and kidney transplantation. Int J Nephrol (2011) 0.77

Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function. Clin Diagn Lab Immunol (1997) 0.76

Articles by these authors

Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66

National estimates of blood lead levels: United States, 1976-1980: association with selected demographic and socioeconomic factors. N Engl J Med (1982) 5.64

Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell (1996) 5.10

Jack Kevorkian: a medical hero. BMJ (1996) 4.87

Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev (2001) 4.64

Roles for Nkx3.1 in prostate development and cancer. Genes Dev (1999) 4.30

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03

Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr (1999) 3.98

The public versus the World Health Organization on health system performance. Health Aff (Millwood) (2001) 3.96

Natural history of HIV infection. AIDS (1989) 3.75

Predicting child abuse: signs of bonding failure in the maternity hospital. Br Med J (1977) 3.70

HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS (1994) 3.67

Publishing research supported by the tobacco industry. BMJ (1996) 3.65

"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33

Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci (2000) 3.16

Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04

Prevalence of myopia in the United States. Arch Ophthalmol (1983) 3.00

Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97

Interobserver agreement and disagreement in continuous recording exemplified by measurement of behavior state. Am J Ment Retard (1997) 2.95

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91

Joint teleconsultations (virtual outreach) versus standard outpatient appointments for patients referred by their general practitioner for a specialist opinion: a randomised trial. Lancet (2002) 2.62

Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62

Revised "joint statement" clarifies relationships between midwives and physician collaborators. J Midwifery Womens Health (2001) 2.60

HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60

Debate over US Gulf war syndrome continues. BMJ (1994) 2.54

Specialists in the United States: what lessons? BMJ (1995) 2.53

Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem (1999) 2.51

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50

An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.49

Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology (2008) 2.44

Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res (1993) 2.43

Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature (1983) 2.41

Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ (2012) 2.39

General practice observed. Child abuse and general practice. Br Med J (1976) 2.39

Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37

Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases. J Biol Chem (1997) 2.34

Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science (2013) 2.33

Body mass index: a comparison between self-reported and measured height and weight. J Public Health Med (1998) 2.32

Does contingent reinforcement strengthen operant behavior? J Exp Anal Behav (1987) 2.31

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens (2014) 2.29

Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol (1996) 2.26

Resurgence of sleeping sickness in Tambura County, Sudan. Am J Trop Med Hyg (1999) 2.24

The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22

Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda: complexes with lambda O protein and with lambda O, lambda P, and Escherichia coli DnaB proteins. Proc Natl Acad Sci U S A (1985) 2.19

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18

Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17

Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem (1990) 2.16

Non-response bias in a lifestyle survey. J Public Health Med (1997) 2.10

Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09

Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09

Classification and definition of major flares in SLE clinical trials. Lupus (1999) 2.02

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00

Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97

Where next for prophylaxis against pre-eclampsia? Br J Obstet Gynaecol (1996) 1.95

Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2001) 1.95

Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med (1988) 1.92

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92

Vector analysis of astigmatism. Adding and subtracting spherocylinders. J Cataract Refract Surg (1993) 1.87

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc (2000) 1.87

Micro-organisms in gastroenteritis. Arch Dis Child (1984) 1.86

Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol (1998) 1.85

Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood (2000) 1.84

Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81

Medical profession at last speaks out over abortion. BMJ (1995) 1.81

Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80

Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J Virol (1995) 1.80

Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion (1994) 1.78

L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78

Simple and complex cell cycles. Annu Rev Cell Biol (1989) 1.77

Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell (1999) 1.75

The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74

The complete nucleotide sequence of the glnALG operon of Escherichia coli K12. Nucleic Acids Res (1987) 1.73

Dominant mobility modulation by the electric field effect at the LaAlO3/SrTiO3 interface. Phys Rev Lett (2009) 1.72

Prehospital stability of diazepam and lorazepam. Am J Emerg Med (1999) 1.72

Validation of two methods of data collection of self-reported medicine use among the elderly. Gerontologist (1988) 1.70

DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70

Behavior states: now you see them, now you don't. Am J Ment Retard (1999) 1.68

Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis (1990) 1.67

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Determinants of patient satisfaction in postmastectomy breast reconstruction. Plast Reconstr Surg (2000) 1.67

Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages. Am Rev Respir Dis (1977) 1.64

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med (2002) 1.63

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet (1992) 1.63